AVGN Insider Trading Activity and SEC Form 4 Filings
AVGN insider trading summary
No open-market insider purchases or sales of Avigen Inc \de (AVGN) have been reported on SEC Form 4 in the past 12 months.
Latest AVGN insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Dec 16, 2009 | Burlingame Asset Management, LLC | 10% Owner | Buy | $19K (14,159 @ $1.33) |
| Dec 16, 2009 | Burlingame Asset Management, LLC | 10% Owner | Sell | $236K (181,526 @ $1.30) |
| Dec 15, 2009 | Burlingame Asset Management, LLC | 10% Owner | Buy | $221K (167,367 @ $1.32) |
| Dec 14, 2009 | Burlingame Asset Management, LLC | 10% Owner | Buy | $1.7M (1,280,203 @ $1.35) |
| Nov 19, 2009 | Zola P Horovitz | Director | Sell | $7K (5,000 @ $1.43) |
| Nov 18, 2009 | Mark N Lampert | 10% Owner | Sell | $939 (626 @ $1.50) |
| Nov 18, 2009 | Bvf Inc/Il | 10% Owner | Sell | $939 (626 @ $1.50) |
| Nov 18, 2009 | Bvf Partners L P/Il | 10% Owner | Sell | $939 (626 @ $1.50) |
| Nov 18, 2009 | Bvf Investments LLC | Insider | Sell | $939 (626 @ $1.50) |
| Nov 18, 2009 | Biotechnology Value Fund L P | Insider | Sell | $939 (626 @ $1.50) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.